To comprehensively evaluate the role of HSD3B1 genotypes, our study integrates germline genotype inference with transcriptomic and genomic profiling to analyze its influence on tumor biology and clinical outcomes in BC and EC, stratified by inferred menopausal status and cancer subtype. This evidence concerns the gene HSD3B1 and breast cancer.